Why VitaSmart’s FDA nod could shift transplant strategies for extended-criteria grafts
Find out how Bridge to Life’s FDA-cleared VitaSmart system could reshape liver transplant workflows in 2026.
Medical Devices & Diagnostics
Pharma & Biotech
LifeNet Health acquires Tissue Testing Technologies to scale biopreservation in regenerative medicine
LifeNet Health has announced the acquisition of Tissue Testing Technologies LLC (T3), a South Carolina–based biotechnology company specializing in advanced biopreservation. The deal expands LifeNet Health’s capabilities in organ and tissue preservation by integrating proprietary vitrification and warming technologies developed by Tissue Testing Technologies. The transaction is positioned to enhance clinical transplantation success rates, support